Puducherry's health authorities have initiated disciplinary action against Drugs Inspector E. Anandakirouchenane following a major investigation into counterfeit pharmaceutical manufacturing operations. The suspension stems from allegations of inadequate oversight and insufficient enforcement measures against illegal drug production facilities. This regulatory action highlights growing concerns regarding medicine quality control and consumer safety in the pharmaceutical sector, prompting authorities to strengthen monitoring mechanisms across the region.

Summary auto-generated by AI from the original publisher's content. Editorial standards.